Cardiac recovery after single, low esmolol dose in patients undergoing valve replacement surgery. A randomized controlled double-blind study
Not Applicable
Completed
- Conditions
- Circulatory Systemeffect of esmolol on cardiac recovery during CPB surgeryCardiology
- Registration Number
- PACTR201801003026226
- Lead Sponsor
- menoufiya faculty of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
includes all patients with rheumatic heart disease undergoing valve replacement therapy
Exclusion Criteria
Patients with pericarditis were excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie esmolol's effect on cardiac recovery during CPB surgery in valve replacement patients?
How does a single low-dose esmolol intervention compare to standard beta-blocker protocols in post-valve surgery cardiac recovery?
Are there specific biomarkers that predict enhanced cardiac recovery with esmolol in patients undergoing CPB for valve replacement?
What adverse events are associated with low-dose esmolol administration during CPB and how are they managed clinically?
How do esmolol's beta-blocking properties interact with other cardioprotective agents used in valve replacement surgery?